CS McKee’s Impax Laboratories, Inc. IPXL Stock Holding History

CS McKee’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-106,807	Closed	-$2.53M	–	108
2014 Q3	$2.53M	Sell	106,807 -202,673	-65%	-$5.19M	0.06%	99
2014 Q2	$9.21M	Sell	309,480 -55,880	-15%	-$1.51M	0.2%	90
2014 Q1	$9.65M	Sell	365,360 -38,610	-10%	-$965K	0.21%	90
2013 Q4	$10.2M	Sell	403,970 -271,370	-40%	-$6.05M	0.2%	90
2013 Q3	$13.8M	Sell	675,340 -38,070	-5%	-$786K	0.24%	96
2013 Q2	$14.2M	Buy	+713,410	New	+$12.7M	0.24%	100

Other funds holding IPXL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

CS McKee's IPXL Position: Q4 2014 in Review

CS McKee sold out of Impax Laboratories, Inc. (IPXL) in Q4 2014, closing a stake of 106,807 shares — an estimated $2.53M sold.

CS McKee first reported a position in IPXL in Q2 2013 and held it in 6 quarters. The position peaked at $14.2M in Q2 2013. 178 funds tracked by Wall St. Rank hold IPXL as of Q4 2014.

CS McKee reported no remaining Impax Laboratories, Inc. position as of Q4 2014 after selling out during the quarter.
CS McKee sold 106,807 Impax Laboratories, Inc. shares in Q4 2014, an estimated $2.53M.
CS McKee first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 6 quarters.
CS McKee's Impax Laboratories, Inc. position peaked at $14.2M in Q2 2013.
178 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2014.

Based on CS McKee's 13F filing for Q4 2014, filed 13 Feb 2015.